Citation: R. Williams et Sm. Riordan, Acute liver failure: Established and putative hepatitis viruses and therapeutic implications, J GASTR HEP, 15, 2000, pp. G17-G25

Natural history of chronic hepatitis B virus infection

Authors: Yuen, MF Lai, CL

Citation: Mf. Yuen et Cl. Lai, Natural history of chronic hepatitis B virus infection, J GASTR HEP, 15, 2000, pp. E20-E24

Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury

Authors: Enomoto, N Ikejima, K Bradford, BU Rivera, CA Kono, H Goto, M Yamashina, S Schemmer, P Kitamura, T Oide, H Takei, Y Hirose, M Shimizu, H Miyazaki, A Brenner, DA Sato, N Thurman, RG

Citation: N. Enomoto et al., Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury, J GASTR HEP, 15, 2000, pp. D20-D25

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

Authors: Chu, CM

Citation: Cm. Chu, Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma, J GASTR HEP, 15, 2000, pp. E25-E30

Intestinal failure

Authors: Irving, M

Citation: M. Irving, Intestinal failure, J GASTR HEP, 15, 2000, pp. G26-G29

Molecular mechanism of the reversibility of hepatic fibrosis: With specialreference to the role of matrix metalloproteinases

Authors: Okazaki, I Watanabe, T Hozawa, S Arai, M Maruyama, K

Citation: I. Okazaki et al., Molecular mechanism of the reversibility of hepatic fibrosis: With specialreference to the role of matrix metalloproteinases, J GASTR HEP, 15, 2000, pp. D26-D32

Helicobacter pylori: Past, present and future

Authors: Tytgat, GNJ

Citation: Gnj. Tytgat, Helicobacter pylori: Past, present and future, J GASTR HEP, 15, 2000, pp. G30-G33

Treatment of chronic hepatitis B virus infection: who, when, what for and how

Authors: Liaw, YF

Citation: Yf. Liaw, Treatment of chronic hepatitis B virus infection: who, when, what for and how, J GASTR HEP, 15, 2000, pp. E31-E33

Gene therapy for liver cirrhosis

Authors: Fujimoto, J

Citation: J. Fujimoto, Gene therapy for liver cirrhosis, J GASTR HEP, 15, 2000, pp. D33-D36

Fading boundary between gastroenterology and surgery

Authors: Cotton, PB

Citation: Pb. Cotton, Fading boundary between gastroenterology and surgery, J GASTR HEP, 15, 2000, pp. G34-G37

Interferon monotherapy in chronic hepatitis B

Authors: Guan, R

Citation: R. Guan, Interferon monotherapy in chronic hepatitis B, J GASTR HEP, 15, 2000, pp. E34-E40

Regulatory mechanism of acid secretion in the damaged stomach: Role of endogenous nitric oxide

Authors: Takeuchi, K Araki, H Kawauchi, S Kunikata, T Mizoguchi, H Tashima, K

Citation: K. Takeuchi et al., Regulatory mechanism of acid secretion in the damaged stomach: Role of endogenous nitric oxide, J GASTR HEP, 15, 2000, pp. D37-D45

Novel targets for the pharmacotherapy of diarrhoea: A view for the millennium

Authors: Farthing, MJG

Citation: Mjg. Farthing, Novel targets for the pharmacotherapy of diarrhoea: A view for the millennium, J GASTR HEP, 15, 2000, pp. G38-G45

Role of steroid priming in the treatment of chronic hepatitis B

Authors: Yokosuka, O

Citation: O. Yokosuka, Role of steroid priming in the treatment of chronic hepatitis B, J GASTR HEP, 15, 2000, pp. E41-E45

Molecular pathogenesis of viral hepatitis

Authors: Locarnini, S

Citation: S. Locarnini, Molecular pathogenesis of viral hepatitis, J GASTR HEP, 15, 2000, pp. G46-G48

Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury

Authors: Suzuki, H Ishii, H

Citation: H. Suzuki et H. Ishii, Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury, J GASTR HEP, 15, 2000, pp. D46-D54

Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection

Authors: Lau, GKK

Citation: Gkk. Lau, Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection, J GASTR HEP, 15, 2000, pp. E46-E52

Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: Proposal for a new classification system of gastrointestinal epithelial neoplasia

Authors: Schlemper, RJ Kato, Y Stolte, M

Citation: Rj. Schlemper et al., Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: Proposal for a new classification system of gastrointestinal epithelial neoplasia, J GASTR HEP, 15, 2000, pp. G49-G57

Nucleoside analogues in the treatment of chronic hepatitis B

Authors: Leung, N

Citation: N. Leung, Nucleoside analogues in the treatment of chronic hepatitis B, J GASTR HEP, 15, 2000, pp. E53-E60

Helicobacter pylori infection and gastric carcinoma in animal models

Authors: Fujioka, T Honda, S Tokieda, M

Citation: T. Fujioka et al., Helicobacter pylori infection and gastric carcinoma in animal models, J GASTR HEP, 15, 2000, pp. D55-D59

Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract

Authors: Sung, JJY Russell, RI Yeomans, N Chan, FKL Chen, SL Fock, KM Goh, KL Kullavanijaya, P Kimura, K Lau, CS Louw, J Sollano, J Triadiafalopulos, G Xiao, SD Brooks, P

Citation: Jjy. Sung et al., Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract, J GASTR HEP, 15, 2000, pp. G58-G68

Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>